Zhengping Chen

530 total citations
46 papers, 412 citations indexed

About

Zhengping Chen is a scholar working on Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Zhengping Chen has authored 46 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Cellular and Molecular Neuroscience and 10 papers in Neurology. Recurrent topics in Zhengping Chen's work include Radiopharmaceutical Chemistry and Applications (10 papers), Neuroscience and Neuropharmacology Research (9 papers) and Medical Imaging Techniques and Applications (8 papers). Zhengping Chen is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Neuroscience and Neuropharmacology Research (9 papers) and Medical Imaging Techniques and Applications (8 papers). Zhengping Chen collaborates with scholars based in China, Fiji and United States. Zhengping Chen's co-authors include Mrudula Pullambhatla, Sangeeta Ray Banerjee, Martin G. Pomper, Ala Lisok, Jian Chen, Ronnie C. Mease, Jian Wang, Liqin Yang, Jian Wu and John E. Pintar and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Brain Research.

In The Last Decade

Zhengping Chen

42 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengping Chen China 9 131 99 97 91 71 46 412
Tobias Heinrich Germany 13 77 0.6× 60 0.6× 116 1.2× 52 0.6× 42 0.6× 19 384
Bradford D. Henderson United States 12 267 2.0× 60 0.6× 99 1.0× 47 0.5× 67 0.9× 23 463
Hanno Schieferstein Germany 11 186 1.4× 61 0.6× 129 1.3× 51 0.6× 37 0.5× 23 466
Shimpei Iikuni Japan 13 157 1.2× 56 0.6× 186 1.9× 67 0.7× 52 0.7× 43 502
Holly Turner United States 7 237 1.8× 50 0.5× 146 1.5× 59 0.6× 108 1.5× 7 627
Palamadai N. Venkatasubramanian United States 15 224 1.7× 63 0.6× 169 1.7× 82 0.9× 65 0.9× 37 731
Maarten Ooms Belgium 14 275 2.1× 52 0.5× 117 1.2× 28 0.3× 86 1.2× 32 457
Marcel Cleij United Kingdom 12 304 2.3× 61 0.6× 190 2.0× 43 0.5× 93 1.3× 17 712
Johan Ulin Sweden 13 250 1.9× 158 1.6× 226 2.3× 50 0.5× 51 0.7× 27 663
Talakad G. Lohith United States 13 182 1.4× 169 1.7× 228 2.4× 34 0.4× 43 0.6× 23 587

Countries citing papers authored by Zhengping Chen

Since Specialization
Citations

This map shows the geographic impact of Zhengping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengping Chen more than expected).

Fields of papers citing papers by Zhengping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengping Chen. The network helps show where Zhengping Chen may publish in the future.

Co-authorship network of co-authors of Zhengping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengping Chen. A scholar is included among the top collaborators of Zhengping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengping Chen. Zhengping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jie, et al.. (2024). Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter. Bioorganic & Medicinal Chemistry Letters. 102. 129678–129678. 1 indexed citations
2.
Yang, Xiaolan, et al.. (2023). Elucidating the molecular mechanisms of ozone therapy for neuropathic pain management by integrated transcriptomic and metabolomic approach. Frontiers in Genetics. 14. 1231682–1231682. 3 indexed citations
3.
Li, Qingming, Jie Tang, Yi Fang, et al.. (2023). Deuterated [18F]fluoroethyl tropane analogs as dopamine transporter probes: Synthesis and biological evaluation. Nuclear Medicine and Biology. 118-119. 108334–108334. 2 indexed citations
4.
Fu, Lingling, et al.. (2021). An escalating treatment strategy for children with severe chronic immune thrombocytopenia: Preliminary report from a single center. Pediatric Blood & Cancer. 68(6). e29006–e29006. 2 indexed citations
5.
Liu, Chunyi, Jie Tang, Shanshan Cao, et al.. (2021). Molar activity of [18F]FP-(+)-DTBZ radiopharmaceutical: Determination and its effect on quantitative analysis of VMAT2 autoradiography. Journal of Pharmaceutical and Biomedical Analysis. 203. 114212–114212.
6.
Cao, Shanshan, et al.. (2021). Synthesis and Biological Evaluation of [18F]FECNT-d4 as a Novel PET Agent for Dopamine Transporter Imaging. Molecular Imaging and Biology. 23(5). 733–744. 8 indexed citations
7.
Tang, Jie, Chunyi Liu, Yi Fang, et al.. (2020). PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data. Nuclear Medicine and Biology. 90-91. 1–9. 7 indexed citations
8.
Sun, Yu, et al.. (2020). Phase I clinical study with different doses of 99mTc-TRODAT-1 in healthy adults. Annals of Nuclear Medicine. 34(3). 212–219. 3 indexed citations
9.
10.
Zhao, Chao, et al.. (2019). An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [18F]FP-(+)-DTBZ. Molecular Imaging and Biology. 22(2). 265–273. 6 indexed citations
11.
Hu, Wei‐Lin, et al.. (2015). [Mechanism of tanshinone II A in inhibiting transformation of aortic valvular myofibroblast to osteoblast-like phenotype].. PubMed. 40(18). 3636–43. 1 indexed citations
12.
Chen, Di, et al.. (2015). Effects of oxidized low density lipoprotein on transformation of valvular myofibroblasts to osteoblast-like phenotype. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(3). 362–367. 1 indexed citations
13.
Xie, Cuihong, et al.. (2015). Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts. Aging Clinical and Experimental Research. 28(2). 181–187. 16 indexed citations
14.
Chen, Zhengping, et al.. (2015). Effects of anesthetics on vesicular monoamine transporter type 2 binding to 18 F-FP-(+)-DTBZ: a biodistribution study in rat brain. Nuclear Medicine and Biology. 43(1). 124–129. 9 indexed citations
15.
Chen, Zhengping, et al.. (2013). Animal biodistribution, safety and validation study of dopamine transporter PET imaging agent 18F-FECNT. 《核技术》(英文版). 20(1). 1 indexed citations
16.
Zou, Pei, et al.. (2011). Isopropyl 4-nitrobenzoate. Acta Crystallographica Section E Structure Reports Online. 67(10). o2806–o2806. 1 indexed citations
17.
Chen, Zhengping, et al.. (2008). (2S,3S)-3-(4-Chlorophenyl)-8-methyltropane-2-carboxylic acid. Acta Crystallographica Section E Structure Reports Online. 64(9). o1732–o1732. 3 indexed citations
18.
Wang, Jian, Yuping Jiang, Yihui Guan, et al.. (2007). 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson’s disease in various Hoehn & Yahr stages. Journal of Neurology. 254(2). 185–190. 70 indexed citations
19.
20.
Chen, Zhengping. (1999). Preparation and animal studies of 99 TcmTRODAT1 as a dopamine transporter imaging agent. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Heinrich Breakdown of academic impact, for papers by Bradford D. Henderson Breakdown of academic impact, for papers by Hanno Schieferstein Breakdown of academic impact, for papers by Shimpei Iikuni Breakdown of academic impact, for papers by Holly Turner Breakdown of academic impact, for papers by Palamadai N. Venkatasubramanian Breakdown of academic impact, for papers by Maarten Ooms Breakdown of academic impact, for papers by Marcel Cleij Breakdown of academic impact, for papers by Johan Ulin Breakdown of academic impact, for papers by Talakad G. Lohith
Rankless by CCL
2026